“ Nilotinib treatment decreased serum LDH, alanine aminotransferase, aspartate aminotransferase, and γ‐glutamyltransferase (γ‐GT), hepatic malondialdehyde, and cytochrome‐C. It also increased superoxide dismutase, reduced glutathione , glutathione reductase, glutathione peroxidase, glutathione‐S‐transferase (GST), TAC, and Nrf2 compared to CsA‐injected rats.”